Future Trends in Research in Hypertrophic Cardiomyopathy

  • S. E. Epstein
Conference paper


The past three decades have seen major progress in our understanding of the clinical, hemodynamic, and morphologic abnormalities in hypertrophic cardiomyopathy [1]. Major future advances will undoubtedly relate to an elucidation of the basic cellular abnormalities responsible for this fascinating syndrome, and perhaps to the identification of specific genetic defects present in this disease.


Hypertrophic Cardiomyopathy Myocardial Hypertrophy Left Ventricular Outflow Tract Obstruction Small Coronary Artery Cytosolic Calcium Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316: 780–789PubMedCrossRefGoogle Scholar
  2. 2.
    Maron BJ, Roberts WC (1979) Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59: 689–706PubMedGoogle Scholar
  3. 3.
    Tanaka M, Fujiwara H, Onodera T, Wu D-J, Hamashima Y, Kawai C (1986) Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 55: 575–581PubMedCrossRefGoogle Scholar
  4. 4.
    Maron BJ, Epstein SE, Roberts WC (1979) Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 43: 1086–1102PubMedCrossRefGoogle Scholar
  5. 5.
    Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545–557PubMedCrossRefGoogle Scholar
  6. 6.
    Goodwin JF (1974) Prospects and predictions for the cardiomyopathies. Circulation 560: 210Google Scholar
  7. 7.
    Pearse AGE (1964) Histochemistry and electronmicroscopy of obstructive cardiomyopathy. CIBA foundation Symposium, Boston. Little, Brown and Co, p 132Google Scholar
  8. 8.
    Perloff JK (1981) Pathogenesis of hypertrophic cardiomyopathy: hypotheses and speculations. Am Heart J 102: 219–226CrossRefGoogle Scholar
  9. 9.
    Laks MM, Morady F, Swan HJF (1973) Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 64: 75–78PubMedCrossRefGoogle Scholar
  10. 10.
    Panagia V, Pierce GN, Dhalla KS, Ganguly PK, Beamish RE, Dhalla NS (1985) Adaptive changes in subcellular calcium transport during catecholamine-induced cardiomyopathy. J Mol Cell Cardiol 17: 411–420PubMedCrossRefGoogle Scholar
  11. 11.
    Starksen NF, Bishopric NH, Coughlin SR, Lee WMF, Ordahl CP, Simpson PC, Williams LT (1985) Adrenergic-stimulated hypertrophy is associated with expression of the C- MYC-proto-oncogene in neonatal rat cardiac cells. (Abstract). Circulation 72 (Suppl III) 111: 26Google Scholar
  12. 12.
    Meideil RS, Sen A, Slahetka MF, Kumar C, Siddiquie MAQ, Chien KR (1985) Stimulation of cultured rat myocardial cells by norepinephrine or phorbol ester increases myofibrillar and non-myofibrillar mRNA content. (Abstract) Circulation 72 (Suppl III) III: 27Google Scholar
  13. 13.
    Simpson P (1983) Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells in an alphax adrenergic response. J Clin Invest 72: 732PubMedCrossRefGoogle Scholar
  14. 14.
    Van Noorden S, Olsen EG, Pearse AGE (1971) Hypertrophic obstructive cardiomyopathy: a histological, histochemical and ultrastructural study of biopsy material. Cardiovasc Res 5: 118PubMedCrossRefGoogle Scholar
  15. 15.
    Kawai C, Yui Y, Hishino T, Sasayama S, Matsumori A (1983) Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study. J Am Coll Cardiol 2: 834–840PubMedCrossRefGoogle Scholar
  16. 16.
    Brush JE, Eisenhofer G, Stull R, Garty M, Maron BJ, Cannon RO, Panza J, Epstein SE, Goldstein DS (1989) Cardiac norepinephrine kinetics in hypertrophic cardiomyopathy. Circulation (in press)Google Scholar
  17. 17.
    Spirito P, Maron BJ, Chiarella F, et al (1985) Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation 72: 310–316PubMedCrossRefGoogle Scholar
  18. 18.
    St John Sutton MG, Tajik AJ, Gibson DG, Brown DJ, Seward JB, Giuliani ER (1978) Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation 57: 512–520Google Scholar
  19. 19.
    Hanrath P, Mathey DG, Siegert R, Bierfield W (1980) Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol 45: 15–23PubMedCrossRefGoogle Scholar
  20. 20.
    Bonow RO, Rosing DR, Bacharach SL, et al (1981) Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 64: 787–796PubMedCrossRefGoogle Scholar
  21. 21.
    Rosing DR, Kent KM, Borer JS, Seides SF, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation 60: 1201–1207PubMedGoogle Scholar
  22. 22.
    Rosing DR, Kent KM, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II: Effects on exercise capacity and symptomatic status. Circulation 60: 1208–1213PubMedGoogle Scholar
  23. 23.
    Wagner JA, Sax FL, Weisman HF, Porterfield J, Mcintosh C, Weisfeldt ML, Snyder SH, Epstein SE (1989) Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl Med 320: 755–761CrossRefGoogle Scholar
  24. 24.
    Casscells W, Speir E (1987) Purification and characterization of heparinbinding mitogens from human left ventricular myocardium. Clin Research 35: 255aGoogle Scholar
  25. 25.
    Karasik P, Lee M, Casscells W, Epstein SE (1989) Identification of heparinbinding growth factors in myocardium of patients with hypertrophic cardiomyopathy (Submitted for publication)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • S. E. Epstein

There are no affiliations available

Personalised recommendations